About the Authors

Mihai G Netea, Tania Azam, Eli C Lewis, Soo-Hyun Kim, Charles A Dinarello
Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, Colorado, United States of America

Mihai G Netea
Nijmegen University Center for Infectious Diseases, Nijmegen, Netherlands

Leo A. B Joosten
Laboratory of Experimental Rheumatology, Radboud University Nijmegen Medical Center, Nijmegen, Netherlands

Maorong Wang, Xianzhong Meng
Division of Surgery, University of Colorado Health Sciences Center, Denver, Colorado, United States of America

Dennis Langenberg, Tom Ottenhoff
Department of Immunohematology and Blood Transfusion, Leiden University, Leiden, Netherlands

Edward D Chan
Division of Pulmonary Sciences, University of Colorado Health Sciences Center, Denver, Colorado, United States of America

Do-Young Yoon
Department of Bioscience and Biotechnology, Konkuk University, Seoul, Korea

Soo-Hyun Kim
Department of Biomedical Science and Technology, Konkuk University, Seoul, Korea

Corresponding Author

M.Netea@aig.umcn.nl

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

MGN, DL, TO, SHK, and CAD designed the study. TA, ECL, LABJ, MW, DL, and XM collected data or did experiments for the study. TA helped generate recombinant IL-32. LABJ participated in IL-32 expression of PBMCs after exposure to LPS and MTB. MW participated in the immunocytochemistry for IL-32 staining in PBMCs treated with different stimuli and took the picture. DL provided the necessary mycobacterial stimulating components and help in using them in the experiments. DYY prepared anti-IL-32 antibodies. CAD developed the assays also. EDC participated in intellectual input and discussions with MGN. MGN, XM, TO, SHK, and CAD analyzed the data. MGN, EDC, TO, and CAD contributed to writing the paper.